Abstract:Chronic lower back pain caused by intervertebral disc degeneration and osteoarthritis (OA) are highly prevalent chronic diseases. Although pain management and surgery can alleviate symptoms, no disease-modifying treatments are available. mRNA delivery could halt inflammation and degeneration and induce regeneration by overexpressing anti-inflammatory cytokines or growth factors involved in cartilage regeneration. Here, we investigated poly(amidoamine)-based polymeric nanoparticles to deliver mRNA to human joint and intervertebral disc cells. Human OA chondrocytes, human nucleus pulposus (NP) cells, human annulus fibrosus (AF) cells, fibroblast-like synoviocytes (FLS) and M1-like macrophages were cultured and transfected with uncoated or PGA-PEG-coated nanoparticles loaded with EGFP-encoding mRNA. Cell viability and transfection efficiency were analyzed for all cell types. Nanoparticle internalization was investigated in FLS and M1-like macrophages. No significant decrease in cell viability was observed in most conditions. Only macrophages showed a dose-dependent reduction of viability. Transfection with either nanoparticle version resulted in EGFP expression in NP cells, AF cells, OA chondrocytes and FLS. Macrophages showed internalization of nanoparticles by particle–cell co-localization, but no detectable expression of EGFP. Taken together, our data show that poly (amidoamine)-based nanoparticles can be used for mRNA delivery into cells of the human joint and intervertebral disc, indicating its potential future use as an mRNA delivery system in OA and IVDD, except for macrophages.

What problem does this paper attempt to address?

### Problems Addressed by the Paper This paper aims to address the issue of chronic low back pain (CLBP) caused by intervertebral disc degeneration (IVDD) and osteoarthritis (OA). Although existing pain management and surgical treatments can alleviate symptoms, there are currently no treatments that can alter the disease progression. The authors propose that by delivering mRNA to disc and joint cells, it is possible to overexpress anti-inflammatory cytokines or growth factors involved in cartilage regeneration, thereby inhibiting inflammation and degeneration and promoting regeneration. Therefore, the focus of the research is to develop an effective mRNA delivery system, specifically using polyamide-amine (PAA)-based polymer nanoparticles to achieve this goal. ### Research Background - **High Prevalence**: Intervertebral disc degeneration and osteoarthritis are common chronic diseases among adults worldwide, leading to pain and disability. - **Limitations of Existing Treatments**: - **Pharmacological Treatment**: Can only alleviate symptoms to a limited extent and cannot stop degeneration or promote regeneration. - **Surgical Treatment**: Such as joint replacement and partial discectomy, although effective, have risks of poor long-term outcomes and complications. - **Potential of Gene Therapy**: By delivering mRNA, it is possible to overexpress specific therapeutic molecules, such as anti-inflammatory cytokines or growth factors, providing a new therapeutic approach. ### Research Objectives - **Evaluate Delivery Efficiency of Nanoparticles**: Study the mRNA delivery efficiency of PAA-based polymer nanoparticles in human joint and disc cells. - **Safety Evaluation**: Assess the impact of nanoparticles on cell viability to ensure their safety in clinical applications. - **Cell Types**: Include human OA chondrocytes, nucleus pulposus (NP) cells, annulus fibrosus (AF) cells, fibroblast-like synoviocytes (FLS), and M1-like macrophages. ### Key Findings - **Cell Viability**: Under most conditions, nanoparticles did not significantly affect cell viability, but macrophages showed a dose-dependent decrease in viability. - **Transfection Efficiency**: PAA-based nanoparticles successfully achieved EGFP expression in NP cells, AF cells, OA chondrocytes, and FLS, but no EGFP expression was detected in M1-like macrophages. - **Endocytosis**: Co-localization experiments confirmed that nanoparticles were endocytosed by FLS and M1-like macrophages, but only the former showed significant EGFP expression. ### Conclusion PAA-based polymer nanoparticles can effectively deliver mRNA to human joint and disc cells, showing potential future applications in the treatment of OA and IVDD, but are not suitable for macrophages. This study provides important foundational data for the development of new gene therapies.

Polymeric Nanoparticles Enable mRNA Transfection and Its Translation in Intervertebral Disc and Human Joint Cells, Except for M1 Macrophages

Anti-Inflammatory Therapy for Temporomandibular Joint Osteoarthritis Using mRNA Medicine Encoding Interleukin-1 Receptor Antagonist

Highly efficient healing of critical sized articular cartilage defect in situ using a chemically nucleoside-modified mRNA-enhanced cell therapy

Cartilage-Targeting Mrna-Lipid Nanoparticles Rescue Perifocal Apoptotic Chondrocytes for Integrative Cartilage Repair

LNP-mRNA Delivers TNF-α Antibody to Deep Cartilage and Protects Against Osteoarthritis

Runx1 Messenger RNA Delivered by Polyplex Nanomicelles Alleviate Spinal Disc Hydration Loss in a Rat Disc Degeneration Model

Lipid Nanoparticle Delivery of Chemically Modified NGFR100W mRNA Alleviates Peripheral Neuropathy

Targeted Therapy of Osteoarthritis via Intra‐Articular Delivery of Lipid‐Nanoparticle‐Encapsulated Recombinant Human FGF18 mRNA

A Polymeric Nanoparticle Formulation for Targeted mRNA Delivery to Fibroblasts

Hydrophobic Optimization of Functional Poly(TPAE-co-suberoyl chloride) for Extrahepatic mRNA Delivery following Intravenous Administration

A scalable and robust cationic lipid/polymer hybrid nanoparticle platform for mRNA delivery

Anti-inflammatory Chitosan/Poly-γ-glutamic acid nanoparticles control inflammation while remodeling extracellular matrix in degenerated intervertebral disc

Nanopolymers Delivery of the Bone Morphogenetic Protein-4 Plasmid to Mesenchymal Stem Cells Promotes Articular Cartilage Repair in Vitro and in Vivo

Co‐Polymer Carrier with Dual Advantages of Cartilage‐Penetrating and Targeting Improves Delivery and Efficacy of microRNA Treatment of Osteoarthritis

Exploring the translational potential of PLGA nanoparticles for intra-articular rapamycin delivery in osteoarthritis therapy

Charge‐Reversed Exosomes for Targeted Gene Delivery to Cartilage for Osteoarthritis Treatment

Incorporation of poly(γ-glutamic acid) in lipid nanoparticles for enhanced mRNA delivery efficiency in vitro and in vivo

Injectable nanofibrous spongy microspheres for NR4A1 plasmid DNA transfection to reverse fibrotic degeneration and support disc regeneration

Local mRNA Delivery from Nanocomposites Made of Gelatin and Hydroxyapatite Nanoparticles

MicroRNA-224-5p nanoparticles balance homeostasis via inhibiting cartilage degeneration and synovial inflammation for synergistic alleviation of osteoarthritis

NON-VIRAL REPROGRAMMING OF HUMAN NUCLEUS PULPOSUS CELLS WITH FOXF1 VIA EXTRACELLULAR VESICLE DELIVERY: AN IN VITRO AND IN VIVO STUDY